Injection/Infusion
TYSABRI CONCENTRATE FOR SOLUTION FOR INFUSION 300MG
Summary
TYSABRI CONCENTRATE FOR SOLUTION FOR INFUSION 300MG — Injection/Infusion containing natalizumab. Hong Kong Registration No. HK-61519. Certificate Holder: EISAI (HONG KONG) COMPANY LIMITED. Date of Registration: 12 Nov, 2012.
Product NameTYSABRI CONCENTRATE FOR SOLUTION FOR INFUSION 300MG
Registration No.HK-61519
Certificate HolderEISAI (HONG KONG) COMPANY LIMITED
Holder AddressFLAT/RM A, 29/F, LEE & MAN COMMERCIAL CENTER, 169 ELECTRIC ROAD, NORTH POINT, HONG KONG
Ingredientsnatalizumab
Dosage FormInjection/Infusion
Legal ClassificationPart 1, Schedule 1 & Schedule 3 Poison
Sale RequirementPrescription only Medicines
Date of Registration12 Nov, 2012
ATC codesL04AG03
ATC Classification
ATC level 1
L Antineoplastic and Immunomodulating Agents
All ATC groupsL04
本頁為藥物資料查詢工具，並非藥物廣告、推廣或醫療建議。所有資料取自香港特別行政區衞生署藥物辦公室之公開資料，僅供參考；一切以藥物辦公室官方公布為準。 本頁不提供任何療效、適應症或治療用途之陳述。用藥前請諮詢醫生或註冊藥劑師。 本網站遵守香港法例第 231 章《不良廣告（醫藥）條例》之規管。